Free Rheumatology CME

In this online, self-learning activity:

Lupus nephritis (LN) is a severe manifestation of systemic lupus erythematosus (SLE), affecting over 40% of patients with lupus. It is a major contributor to morbidity, healthcare utilization, and progression to end-stage renal disease (ESRD). The prevalence of LN has increased significantly over time, from 16.8 per 100,000 in 1985 to 21.2 per 100,000 more recently. The mortality rate associated with LN remains high with a standardized mortality ratio of 6.33 compared to the general population. Despite increased advances in treatments, long-term survival rates have not improved significantly over the past four decades. The 10-year survival rate is around 70%, while the incidence of progression in ESRD in LN patients affects up to 13% of patients over time.